BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

13033 related articles for article (PubMed ID: 10761797)

  • 1. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.
    Gershenwald JE; Mansfield PF; Lee JE; Ross MI
    Ann Surg Oncol; 2000 Mar; 7(2):160-5. PubMed ID: 10761797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
    Gershenwald JE; Thompson W; Mansfield PF; Lee JE; Colome MI; Tseng CH; Lee JJ; Balch CM; Reintgen DS; Ross MI
    J Clin Oncol; 1999 Mar; 17(3):976-83. PubMed ID: 10071292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
    Gershenwald JE; Colome MI; Lee JE; Mansfield PF; Tseng C; Lee JJ; Balch CM; Ross MI
    J Clin Oncol; 1998 Jun; 16(6):2253-60. PubMed ID: 9626228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
    Porter GA; Ross MI; Berman RS; Lee JE; Mansfield PF; Gershenwald JE
    Ann Surg Oncol; 2000 May; 7(4):256-61. PubMed ID: 10819364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.
    Landi G; Polverelli M; Moscatelli G; Morelli R; Landi C; Fiscelli O; Erbazzi A
    J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):35-45. PubMed ID: 10877250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lymphatic drainage in patients with grossly involved nodal basins.
    Kamath D; Brobeil A; Stall A; Lyman G; Cruse CW; Glass F; Fenske N; Messina J; Berman C; Reintgen D
    Ann Surg Oncol; 1999 Jun; 6(4):345-9. PubMed ID: 10379854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
    Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
    World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsy.
    Jacobs IA; Chang CK; Salti GI
    J Am Acad Dermatol; 2003 Oct; 49(4):615-9. PubMed ID: 14512905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
    Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
    J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
    Fujisawa Y; Otsuka F;
    Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 652.